172 related articles for article (PubMed ID: 22278138)
1. Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients.
Boschmann M; Nussberger J; Engeli S; Danser AH; Yeh CM; Prescott MF; Dahlke M; Jordan J
J Hypertens; 2012 Mar; 30(3):561-6. PubMed ID: 22278138
[TBL] [Abstract][Full Text] [Related]
2. Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
Engeli S; May M; Nussberger J; Danser AHJ; Dole WP; Prescott MF; Dahlke M; Stitah S; Pal P; Boschmann M; Jordan J
J Am Soc Hypertens; 2017 Aug; 11(8):488-497. PubMed ID: 28666704
[TBL] [Abstract][Full Text] [Related]
3. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
5. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibition with aliskiren.
Wuerzner G; Azizi M
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):426-30. PubMed ID: 18307734
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
Gradman AH; Traub D
Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
[TBL] [Abstract][Full Text] [Related]
8. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
Horký K
Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction.
Ito S; Nakura N; Le Breton S; Keefe D
Hypertens Res; 2010 Jan; 33(1):62-6. PubMed ID: 19927154
[TBL] [Abstract][Full Text] [Related]
10. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
[TBL] [Abstract][Full Text] [Related]
12. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
[TBL] [Abstract][Full Text] [Related]
13. Renin inhibition in hypertension.
Gradman AH; Kad R
J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
Rashikh A; Ahmad SJ; Pillai KK; Najmi AK
J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
[TBL] [Abstract][Full Text] [Related]
16. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
Sanoski CA
Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren: the first direct renin inhibitor available for clinical use.
Morganti A; Lonati C
J Nephrol; 2011; 24(5):541-9. PubMed ID: 21786226
[TBL] [Abstract][Full Text] [Related]
19. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren versus ramipril in hypertension.
Verdecchia P; Angeli F; Mazzotta G; Martire P; Garofoli M; Gentile G; Reboldi G
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):193-200. PubMed ID: 20418269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
